REVEN - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 86623712
Serial Number
86623712
Registration Number
5686415
Word Mark
REVEN
Status
700 - Registered
Status Date
2019-02-26
Filing Date
2015-05-08
Registration Number
5686415
Registration Date
2019-02-26
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2015-10-27
Attorney Name
Michael F. Snyder
Law Office Assigned Location Code
M80
Employee Name
JACKSON, WILLIAM D
Statements
Goods and Services
Pharmaceutical research and development in the fields of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease; Pharmaceutical services, namely, the development of pharmaceuticals for the treatment of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease
Translation of Words in Mark
The wording "REVEN" has no meaning in a foreign language.
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2015-05-18
Primary Code
042
First Use Anywhere Date
2018-12-21
First Use In Commerce Date
2018-12-21
Current Trademark Owners
Party Name
Reven Pharmaceuticals, Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Reven Pharmaceuticals, Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Reven Pharmaceuticals, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Reven Pharmaceuticals, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
MICHAEL F. SNYDER
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2015-05-12NEW APPLICATION ENTERED IN TRAM
2015-05-18NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2015-08-19ASSIGNED TO EXAMINER
2015-08-21EXAMINERS AMENDMENT -WRITTEN
2015-08-21EXAMINERS AMENDMENT E-MAILED
2015-08-21NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2015-08-21EXAMINER'S AMENDMENT ENTERED
2015-08-21APPROVED FOR PUB - PRINCIPAL REGISTER
2015-09-16ASSIGNED TO LIE
2015-09-21LAW OFFICE PUBLICATION REVIEW COMPLETED
2015-10-07NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2015-10-27PUBLISHED FOR OPPOSITION
2015-10-27OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2015-12-22NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2016-06-22TEAS EXTENSION RECEIVED
2016-06-22EXTENSION 1 FILED
2016-06-22EXTENSION 1 GRANTED
2016-06-24NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2016-12-22TEAS EXTENSION RECEIVED
2016-12-22EXTENSION 2 FILED
2016-12-22EXTENSION 2 GRANTED
2016-12-24NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2017-06-22TEAS EXTENSION RECEIVED
2017-06-22EXTENSION 3 FILED
2017-06-22EXTENSION 3 GRANTED
2017-06-24NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2017-12-21TEAS EXTENSION RECEIVED
2017-12-21EXTENSION 4 FILED
2017-12-21EXTENSION 4 GRANTED
2017-12-23NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-06-22TEAS EXTENSION RECEIVED
2018-06-25CASE ASSIGNED TO INTENT TO USE PARALEGAL
2018-06-22EXTENSION 5 FILED
2018-06-25EXTENSION 5 GRANTED
2018-06-26NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-12-26TEAS STATEMENT OF USE RECEIVED
2018-12-24USE AMENDMENT FILED
2019-01-07STATEMENT OF USE PROCESSING COMPLETE
2019-01-23ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2019-01-24NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2019-02-26REGISTERED-PRINCIPAL REGISTER